Contact
Email
role · B2B
c•••@c•••.comc•••@c•••.comSocial
🔒 Contacts are masked. Get full emails & phones. Unlock via export ↗
Category
Primary
pharmaceutical-drugs · embed-ft 0.39
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
cAMPfield Therapeutics | Redefining the Treatment of Inflammatory Diseases
Description
cAMPfield Therapeutics is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for inflammatory bowel disease (IBD). Founded by the teams behind Entyvio®, Humira®, Otezla®, and Zeposia®.
Final URL
Language
en (html)
Scanned at
2026-06-20 02:42:46